Title: ???????? Epidemiology of Cancer
1 ???????? Epidemiology of Cancer
?????????????? Department of epidemiology
,Harbin Medical University
2 ? ? (Status)
- ????(Cancer)??????????????,?100????????????
??,??????????????????????,????????????????????????
2015?,??????????900?,?????1500?,????????????????
In 201515x106 people suffer from cancer 2/3
in developing country Motility will reach to
9x106
3?? (Introduction) ???????????? (Study method of
epidemiology) ?????????? (Prevelence states)
4- ????????????
- (Cancer prevelence of China)
- ?????????
- (Risk factors of cancer)
- ???????
- (Prevention of cancer)
5??
(Concept)
- ????????????????????????????,????,???????????
?????????
6Definition
- (1) Cancer epidemiology is the study of
- the pattern of cancer in populations.
- (2) Its essential aim is to identify causes of
cancer, including preventable (avoidable) causes
and inherited tumor susceptibility.
7- (3) It is also play an critical role in many
- other areas of cancer research including
- evaluation of screening effects, cancer
- prevention and control
- (4) Current studies directions includes
- molecular and genetic epidemiology of
- cancer.
8??? ? ?(Introduction)
- ? ?????
- ?????????????????????????????????
9(No Transcript)
101.??????????(Pathological Features )
- 1)??(cell) ?????????????????????(differentiatio
n)?????,????????????????,?????
11Molecular pathologic Technology and immune
chemistry methods
- ??????????????DNA?????????????????????????
???? - ????????????????????????????????????,??????
????,??????????????????p53????????????????????
12DNA Technique
- DNA??????????????????????,???????????????????
???????????
13- 2)????(Biomarker)???????????????????,???????
???????????????????????
14- 3)??????????(classification)
- ??????????????????(T),?????(N)????????????(
M)3?????????????,??pTNM??? - ??T????????????,N???????????,M??????????
15(No Transcript)
16- ???????(classification)????????????,????????
???????????????????????????????,???????????? - ???????????3????,????????,???????,??????????
?????,???????????3??????????????
172.????????????(Biological characteristics)
- ????(gene expression)?????(Cell cycle
)?????????????,?????????????????????????????????
18???????? (Biological characteristics)
- ???? ?? ?? ???? ??
- ???? ? ??
- ??? ? ?? - -
-
- ?????????(Immortality ),???(Invasiveness),???(Spre
ading )
19???????(Origin of tumor)
- ?????(Monoclonal theory)
- ????????????????????????????????????????????
(stem-cell)????????????,??????? ??
??????????(BAC),???,???,?????????????k-ras????????
20?????(Polyclonal theory)
- ??????????????????
- ???????????(Genetic analysis )
- ?????????????,?APC???Mshz
- ??????????
21???????????
(Origin of Single center or Multi center)
- ?????(???)
- ???????????????????????,???????????????
- ?????(???)
- ?????????????????,?????,???,?????????????????
- ???????????????
22??? (Oncogene)
- ??????????,??????????.
- ????????????,????????,?????????,??,????,??????????
?? - ??????????????????,?????????DNA????????????????
23?????(Discovery of oncogene)
- 1911? Rous???????(RSV)???????????,?????????
- 1976??RVS??????src??????????,????V-onc?
- 1982??????????????????ras??????? C-onc?
24?????(c-onc)
- 1976?,Bishop?Rous?????????src,????????????????????
??????????????????????,????????????? - ?????????????
25??????? (Mechanisms )
- ???
- ????ras ??189??????????????????????????,?ras
gene ???,ras ??????????,????? - ras proto-oncogene
- 1 12 61 189
- gly gln
- ?
- arg ( G ?C), k-ras oncogene
26??????(Types of Oncogene)
- abl
- bcl
- erb
- fos
- myc
- ras
- sis
- src
- ?100???
27???????
(Sites of oncogene)
- Gene c-onc protein v-onc protein
- src ? ?
- ras ? ?
- myc ? ?
- fps ? ???
- abl ? ?
28??????????(Mechanism of Oncogene)
- ?????
- ras??12??????,G-T
- arg-val, ras???GTP??,
- ?????????
- ras ????????,????????
- ras?CCGG???????,?????????
29ras ?????
(Family members of ras)
- ??????,??????????,?ras????????
- H-ras 11p15.5 ?? ??? ???
- N-ras 1p13.2 ??? ??
- K-ras 12p12.1 ??? ??? ??
-
30????(Cancer-inducing virus)
- ? ? ???? ???
- ????? ????DNA T????
- ??? ????DNA E1A,E1B
- ???? ????DNA EB??
- ????? ??RNA ras,src?
31??????(tumor suppressor gene)
- ??????????????,??????????,??????????????????????
,???????????,??????????????? - 1968?Harris??
- ???? X ????
-
- ???????
- ?? ??? (???????)
32???????????(First discovered Tumor Suppressor
Gene)
- ???????
- ??Rb?????????,??????,???????????????????????
?Rb?????????Rb???????????????,??Rb???????? - del(13) (q14)
33??????????????(Study methods of Cancer
Epidemiology)
- ??????????,??????,????????????????????,?????
???????????????????????????,??????????????????????
???,?????????,?????????????????,??????????????????
????????
34???????????????
- ??????????????????????????????
- ?????????????????????????????????
- ??????????????????????????????,???????????????????
??????
35- ?????????????????????
- ??????????????????????,???????
36???????? (Descriptive epidemiologic study)
To describe the difference in occurrence
of a particular cancer between different groups
(age, gender, race, country, a period of time
for time trend) and to generate the hypothesis
for increased/decreased for the specific tumor
type.
37- ???????????(health information system,HIS)
????????????????????????????????????,?????????????
?HIS????????????????????????????????????????????
????????,?????????
38 2004?8?9?856 --
2004/07/15?????????????????????????? ???????????????????????????,??????????????????????????????,?????????????????????(??????),??2004?6?10????????????????????????????????????,????????????????????????????????????????????????????????????????????,?????????????,?????????????????(??????)????????,????????????????????????????? ?????????????????????????,????????????,??????2004??????
39- ????????????????,???????????????????????????
?,???????????????????????????????,????????????????
?????????????
40- ??????????????????????????????????,?????????
???,??????????????,?????????????
41???????? (Analytic epidemiological study)
- ?????????????????????????????????????????
- ??????????????????????????????????????????????
42- ?????????????????????????????????????????NCI?????
?1998???,1999????????????,??1997?????????????????
???????2000??????????????????????????????????????
?,???????????????????????????????????
43????????
(Experimental epidemiological study)
- ???????????????,?????????????????????????????
44- ??????????????????????,???????????????NCI??
???????????????????,??????????????????????????????
??????32902?,???????????????????????????????????1
998???,????2213?,??????????????,??????????????????
???????????????????????????,?????????????????,????
???????????
45?????????????
(Biomarker and tumor epidemiological study)
- ????????????????????????????,???????????????
????????????????
46 ??????
(Types of Biomarker)
- ????(In doses )
- ????????(Biological effective dose)
- ??????????(Pre-clinical biological effects )
- ??????(Susceptibility marker )
- ????????????????
47Molecular Epidemiology
Breaking Open the Black Box
48Molecular Epidemiology
Exposure
Disease
Biological Effective Dose (Adducts)
Preclinical Biologic Effect (SCE oncogene TSG
inactivation)
Internal Dose (Agent Metabolite)
49(No Transcript)
50- ??? ?????????
- (?????????)
Epidemiological Characteristics of Malignancy
51Measures of Cancer Frequency Incidence
- number of new cases occurring
- can be expressed as an absolute number of cases
per year or as a rate per 100,000 persons per
year. - incidence rate provides approximation to average
risk of developing a cancer and is necessary to
compare risk of disease between populations - reduction in incidence is the appropriate
statistics to use when considering impact of
primary prevention strategies
52Measures of Cancer Frequency Mortality
- number of deaths occurring
- mortality rate is the number of deaths per
100,000 persons per year - mortality rates measure average risk of dying
from a specific cancer - number of deaths is one measure of outcome or
impact of cancer (product of incidence and
fatality of a given cancer) - Fatality, (1-survival), is probability that an
individual with cancer will die from it and is
generally assumed to be most severe sequelae of
disease
53- mortality rate sometimes used as convenient proxy
measure of the risk of acquiring the disease
(incidence) when comparing different groups,
since it is more readily available - BUT we need to assume equal survival or fatality
in the populations being compared - most of time this assumption is not correct, so
it is safer to use mortality as measure of
outcome rather than occurrence
54Measures of Cancer Frequency Prevalence
- NO agreed definition of prevalence of cancer
- number of persons in a defined population alive
at a given time who have had cancer diagnosed at
some time in past - overall prevalence not useful for health care
planning purposes because resource requirements
for treating newly diagnosed patients are very
different from those for supporting long-term
survivors, especially since a large proportion of
long-term survivors can be considered cured
55Measures of Cancer Frequency Prevalence
- partial prevalence limits number of patients to
those diagnosed during fixed time in past and is
more useful prevalence measure of cancer burden - prevalence for cases diagnosed within 1, 3, 5
years are likely to be of relevance to different
stages of cancer therapy initial treatment (1
year), clinical follow-up (3 years) and cure (5
years) - patients still alive 5 years after diagnosis are
considered cured since their death rates are
similar to general population (some exceptions,
like breast cancer)
56Other Measurements Survival
- survival time defined as time that elapsed
between diagnosis and death - most basic measure of patients survival is the
observed survival - 5-year observed survival is percentage of
patients alive after 5 years of follow-up from
date of diagnosis
57Other Measurements Relative Survival
- deaths from other competing causes will lower the
observed survival rates and preclude comparison
between groups where probability of death in the
general population vary - relative survival rate can be calculated to
avoid this problem - relative survival rate is observed survival rate
in a patient group divided by expected survival
of a comparable group in the general population
with respect to age, sex, and calendar period of
investigation
58Other Measurements PYLL
- Potential Years of Life Lost (PYLL) measures how
many years of normal life span are lost due to
deaths from cancer - takes into account both number of deaths and age
at which death occurs - Age-weighting function used to increase the
relative value of adults in productive ages,
i.e., 1 year saved for someone at 20 years old is
valued more than for a person aged 60 years - varying weighting functions can be given
according to quality of these life-years
59- ?????????
- (Distribution of cancer)
(?)???? ???????,???????????????,??????????
,????????????????????????,2020?????80?,????????200
0?,??1200?,??????????????,???????????????
60- ?????,??????????????22?2000?????????1010?,?
?620?????????,??????????????????,?????????????,???
?120?,??110??
In the past 10 years, the prevelence and
mortality of cancer increased to 22.new cases
were 10.1million in 2000,and 6.2 million died.
61- ????????????????????????????????????????????
????????????????????50/10?????10??,???????????,???
??????????????,????????,??????????????
62- ?????,?????????????????1990?,???????????????
???,??10????,8???????????????????????????????????
???????????,???????????????????
63(No Transcript)
64The lung cancer epidemic - UK
65The lung cancer epidemic - Canada
66(No Transcript)
67(No Transcript)
68(No Transcript)
69(No Transcript)
70(No Transcript)
71(No Transcript)
72Tobacco Use in the US, 1900-1999
Per capita cigarette consumption
Male lung cancer death rate
Female lung cancer death rate
Age-adjusted to 2000 US standard
population. Source Death rates US Mortality
Public Use Tapes, 1960-1999, US Mortality
Volumes, 1930-1959, National Center for Health
Statistics, Centers for Disease Control and
Prevention, 2001. Cigarette consumption Us
Department of Agriculture, 1900-1999.
73(No Transcript)
74???????????? (Prevelence tendency in China)
- ??????????????20??????????,?????????????20?
?70???84.58/10????20??90???94.36/10?,???11.56? - ????????????????????,??????????????????????
???????111.85? - ??????69.00????1980??????????????,?1985??
??????,????6,?????????44???
75(No Transcript)
76- ????????????????????????????
- 1.?????????????? ?????????????????????????,?????
??,???????????,????????????????,????????????
77- 2.??????? ?????????,?????????????????????????????
??? - 3.????????????????,????????????,??????????,???????
?,???????????????????????????????????
78????(Risk factors)
- Biological factors
- Psycho-social factors
- ?????
- ??????
- ???????
-
- ??????
- Genetic susceptibility factors
- Environmental physical
- and chemical factors
79?????? ????(physical factors) ????(??????)
????(chemical factors) ?? ?? ????
????????????? ???? ????
80???????(biological factors) ?? HBV HCV
HP HPV EB?? HTLV HIV ??
???? ??? ?????(schistosoma
haematobium)??? ???????(clonorchis
sinensis)????? ?????(schistosoma
japonicum)???
81?????? (Psycho-social factors)
- ?????????????
- ????,????
- ????,????
- ????,???????
- ????,????
82??????? (Genetic susceptibility factors)
83???????(Prevention of Cancer)
84(Prevention strategy)
- ?????????????
- ??????????????
- ???????
- ?????????????
85??????(preventive measures)
???? Primary prevention ???? Secondary
prevention ???? Tertiary prevention
86- ????
- ?????????
- ?????????
- ?????????
- ????
(Primary prevention)
87(Secondary prevention)
88????
(Tertiary prevention)
- ?????????????????
- ????
- ?????????????
- ????????,??????????????